Happy Birthday Penelope
24 is a hearse
Her lips are a curse
I’m really excited for my new band… Not only are they professionals but they already all have so much success. They get invited to indie music awards and they win awards! Indie magazines interview them from all over even the drummer has a number 1 song in Australia! They travel all over the country! They all were or are currently signed to Squidhat records and we are moving 4xs as fast my old band, we write new songs all the time and already have way more fans that only took one month to get as many likes as it took the old band to get in a year; with people asking us to do shows instead of us asking to do shows! It’s so kick ass, pretty soon we will have our first album by the end of the year and signed to squidhats making music videos and getting gigs with professional touring bands. Great things are happening and I’m so excited to become a signed band!
@thenegativenancys #punk #girls #lasvegas #music #diymusic #doubledownsaloon #rrriotgirl (at double down saloon)
Leading Anti-Marijuana Academics Are Paid by Painkiller Drug Companies
As Americans continue to embrace pot—as medicine and for recreational use—opponents are turning to a set of academic researchers to claim that policymakers should avoid relaxing restrictions around marijuana. It’s too dangerous, risky, and untested, they say. Just as drug company-funded research has become incredibly controversial in recent years, forcing major medical schools and journals to institute strict disclosure requirements, could there be a conflict of interest issue in the pot debate?
VICE has found that many of the researchers who have advocated against legalizing pot have also been on the payroll of leading pharmaceutical firms with products that could be easily replaced by using marijuana. When these individuals have been quoted in the media, their drug-industry ties have not been revealed.
Take, for example, Dr. Herbert Kleber of Columbia University. Kleber has impeccable academic credentials, and has been quoted in the press and in academic publications warning against the use of marijuana, which he stresses may cause wide-ranging addiction and public health issues. But when he’s writing anti-pot opinion pieces for CBS News, or being quoted by NPR and CNBC, what’s left unsaid is that Kleber has served as a paid consultant to leading prescription drug companies, including Purdue Pharma (the maker of OxyContin), Reckitt Benckiser (the producer of a painkiller called Nurofen), and Alkermes (the producer of a powerful new opioid called Zohydro).
This is Jaime (hi-me) he was my best friend in high school before he got sent to rehab in MX. He escaped and called me and told me he was with this scary guy at his house. That was the last time I heard from him. He was like my brother I still think about him and miss him dearly. #adrianjaimebatista #jaime #bestfriends